Table 2. The top 20 genes that are significantly changed by 4 h PDBu treatment.
Gene name | Gene Symbol | RefSeq | p-value | Fold-Change |
Epiregulin | EREG | NM_001432 | 3.96E-06 | 14.33 |
matrix metallopeptidase 9 | MMP9 | NM_004994 | 6.72E-06 | 12.97 |
solute carrier family 16, member 6 | SLC16A6 | NM_004694 | 2.24E-05 | 10.47 |
prostaglandin-endoperoxide synthase 2 | PTGS2 | NM_000963 | 2.28E-05 | 10.18 |
leukemia inhibitory factor | LIF | NM_002309 | 3.31E-06 | 10.00 |
dual specificity phosphatase 6 | DUSP6 | NM_001946 | 4.24E-05 | 9.36 |
glutamine-fructose-6-phosphate transaminase 2 | GFPT2 | NM_005110 | 1.67E-05 | 8.76 |
MST131 | MST131 | ENST00000423322 | 4.74E-05 | 8.18 |
interleukin 1, alpha | IL1A | NM_000575 | 6.95E-06 | 8.14 |
interleukin 1, beta | IL1B | NM_000576 | 1.27E-05 | 8.07 |
interleukin 8 | IL8 | NM_000584 | 7.06E-05 | 8.00 |
chemokine (C-C motif) ligand 2 | CCL2 | NM_002982 | 3.58E-04 | 7.68 |
serpin peptidase inhibitor, clade B | SERPINB2 | NM_001143818 | 2.97E-06 | 7.61 |
amphiregulin | AREG | NM_001657 | 9.60E-05 | 7.38 |
inhibin, beta A | INHBA | NM_002192 | 1.25E-05 | 6.88 |
metastasis suppressor 1 | MTSS1 | NM_014751 | 3.20E-05 | 6.86 |
ankyrin repeat domain 1 | ANKRD1 | NM_014391 | 1.59E-04 | -6.65 |
endothelial cell-specific molecule 1 | ESM1 | NM_007036 | 3.20E-05 | 6.51 |
colony stimulating factor 2 (granulocyte-macrophage) | CSF2 | NM_000758 | 1.02E-03 | 6.48 |
early growth response 1 | EGR1 | NM_001964 | 5.31E-05 | 6.45 |